Published in Cancer Weekly, July 9th, 2002
The combination of vinorelbine and cisplatin is a standard first-line regimen in this patient group.
"The data showed that patients who received docetaxel with either cisplatin or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.